Companies: 10,795·Total market cap: $144.5T
Etn. Fr. Colruyt NV

Etn. Fr. Colruyt NV

CUYTFOTCConsumer Defensive● Active
$37.68
+$0.00(+0.00%)
Market Cap$4.5B
P/E Ratio
52W High$44.7
52W Low$37.68

Etn. Fr. Colruyt NV (CUYTF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CUYTF · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-032024-032023-032022-032021-03
Revenue
Revenue$10.96B$10.84B$9.93B$9.25B$9.93B
Cost of Revenue$7.68B$7.61B$9.08B$8.38B$8.92B
Gross Profit$3.29B$3.23B$0.85B$0.87B$1.01B
Gross Margin %(computed)29.99%29.79%8.54%9.46%10.14%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$0.13B$0.10B$0.10B$0.11B
Total Operating Expenses$2.84B$2.76B$0.74B$0.64B$0.66B
Operating Income$0.45B$0.47B$0.11B$0.23B$0.35B
Operating Margin %(computed)4.07%4.33%1.06%2.54%3.48%
Interest Income$0.04B$0.01B$0.00B$0.00B$0.00B
Interest Expense$0.04B$0.02B$0.01B$0.00B$0.00B
Income Before Tax$0.45B$1.18B$0.24B$0.36B$0.52B
Income Tax Expense$0.11B$0.10B$0.06B$0.09B$0.10B
Net Income$0.34B$1.05B$0.20B$0.29B$0.42B
Net Margin %(computed)3.08%9.69%2.02%3.11%4.18%
Per Share & EBITDA
EPS (Basic)$2.73$8.33$1.57$2.17$3.06
Wtd Avg Shares0.12B0.13B0.13B0.13B0.14B
EBITDA$0.90B$0.88B$0.65B$0.72B$0.85B
EBITDA Margin %(computed)8.17%8.08%6.51%7.82%8.54%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B

Explore more Etn. Fr. Colruyt NV data

About Etn. Fr. Colruyt NV (CUYTF) Income Statement

Etn. Fr. Colruyt NV (CUYTF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CUYTF reported revenue of $10.96B, gross profit of $3.29B (gross margin 29.99%), and net income of $0.34B — a net profit margin of 3.08%.

Frequently asked questions

CUYTF · 4 questions

Etn. Fr. Colruyt NV (CUYTF) reported revenue of $10.96B for 2025, up 1.1% year-over-year.

CUYTF revenueCUYTF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08